Overview
- Peptide (C)EFDWKSYIQDSRYH, corresponding to amino acid residues 311 - 324 of mouse SCN1A (Accession A2APX8). Extracellular, 3rd loop.
SCN1A (NaV1.1) (extracellular) Blocking Peptide (BLP-SC051)
- Western blot analysis of rat brain membranes (lanes 1 and 3) and mouse brain membranes (lanes 2 and 4):1-2. Anti-SCN1A (NaV1.1) (extracellular) Antibody (#ASC-051), (1:200).
3-4. Anti-SCN1A (NaV1.1) (extracellular) Antibody, preincubated with SCN1A (NaV1.1) (extracellular) Blocking Peptide (BLP-SC051).
- Expression of Nav1.1 in mouse cerebellumImmunohistochemical staining of perfusion-fixed frozen mouse brain sections with Anti-SCN1A (NaV1.1) (extracellular) Antibody (#ASC-051), (1:100), followed by goat anti-rabbit-AlexaFluor-488. A. Nav1.1 immunoreactivity (green) appears in cerebellar Purkinje cells (vertical arrows) and their dendrites (horizontal arrows). B. Pre-incubation of the antibody with SCN1A (NaV1.1) (extracellular) Blocking Peptide (BLP-SC051), suppressed staining. Cell nuclei are stained with DAPI (blue). P = pyramidal layer, MOL = molecular layer.
- Expression of Nav1.1 in mouse cortexImmunohistochemical staining of perfusion-fixed frozen mouse brain sections with Anti-SCN1A (NaV1.1) (extracellular) Antibody (#ASC-051), (1:100), followed by goat anti-rabbit-AlexaFluor-488. A. Nav1.1 immunoreactivity (green) appears in the cell body of cortical pyramidal neurons (horizontal arrows) and in their dendrites (vertical arrows). B. Pre-incubation of the antibody with SCN1A (NaV1.1) (extracellular) Blocking Peptide (BLP-SC051), suppressed staining. Cell nuclei are stained with DAPI (blue).
- Wu, L. et al. (2002) NeuroReport 13, 2547.
- Fang, X. et al. (2002) J. Neurosci. 22, 7425.
- Fjell, J. et al. (2000) NeuroReport 11, 199.
- Baker, M.D. and Wood, J.N. (2001) Trends Pharmacol. Sci. 22, 27.
- Lai, J. et al. (2003) Curr. Opin. Neurobiol. 13, 291.
- Isom, L.L. (2001) Neuroscientist 7, 42.
- Catterall, W.A. et al. (2003) Pharmacol Rev 55, 575.
- Catterall, W.A. et al. (2008) J. Neurosci. 28, 11768.
- Rhodes, T.H. et al. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 11147.
Voltage-gated sodium channels (NaV) are essential for the generation of action potentials and for cell excitability1. NaV channels are activated in response to depolarization and selectively allow the flow of Na+ ions. To date, nine NaV α subunits have been cloned and named NaV1.1-NaV1.94-5. The NaV channels are classified into two groups according to their sensitivity to tetrodotoxin (TTX): TTX-sensitive (NaV1.1, NaV1.2, NaV1.3, NaV1.4, NaV1.6 and NaV1.7) and TTX-resistant (NaV1.5, NaV1.8 and NaV1.9)2-3.
Mammalian sodium channels are heterotrimers composed of a central, pore-forming α subunit and two auxiliary β subunits. The expression of the α subunit isoform is developmentally regulated and tissue specific. Na+ channels in the adult central nervous system and heart contain β1 through β4 subunits, whereas Na+ channels in adult skeletal muscle have only the β1 subunit6,7.
NaV1.1, also referred to as SCN1A, is a tetrodotoxin-sensitive channel and is broadly expressed in neurons7.
Mutations in NaV1.1 are associated with at least two forms of epilepsy. Gain-of-function missense mutations are a primary cause of generalized epilepsy with febrile seizures plus (GEFS+). Loss-of-function mutations cause severe myoclonic epilepsy of infancy (SMEI)8,9.
Application key:
Species reactivity key:
Anti-SCN1A (NaV1.1) (extracellular) Antibody (#ASC-051) is a highly specific antibody directed against an extracellular epitope of the mouse protein. The antibody can be used in western blot and immunohistochemistry applications. It has been designed to recognize Nav1.1 from mouse, rat and human samples.